Cargando…
Fractional exhaled nitric oxide levels in asthma–COPD overlap syndrome: analysis of the National Health and Nutrition Examination Survey, 2007–2012
PURPOSE: Recent studies propose T(H)2-mediated inflammation in patients with asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS). However, little is known about whether fractional exhaled nitric oxide (FeNO) differs between patients with ACOS and those with COPD alone. To add...
Autores principales: | Goto, Tadahiro, Camargo, Carlos A, Hasegawa, Kohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019187/ https://www.ncbi.nlm.nih.gov/pubmed/27660432 http://dx.doi.org/10.2147/COPD.S110879 |
Ejemplares similares
-
Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD
por: Chen, Feng-jia, et al.
Publicado: (2016) -
Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma–COPD overlap
por: Takayama, Yusuke, et al.
Publicado: (2018) -
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
por: Turner, Steve W., et al.
Publicado: (2019) -
Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma–COPD overlap (ACO): a scoping review protocol
por: Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof, et al.
Publicado: (2017) -
Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity
por: Feng, Jia-Xi, et al.
Publicado: (2017)